David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
CALL
Tesla
TSLA
$1.43T
| $53.7M | 0.07% |
2,877,000
-5,766,000
| -67% | -$116M |
|
352
NOV
NOV
$7.28B
| $53.6M | 0.07% |
2,013,528
+358,695
| +22% | +$10.2M |
|
353
CALL
Morgan Stanley
MS
$336B
| $53.2M | 0.07% |
1,261,200
+338,000
| +37% | +$14.2M |
|
|
QEP
354
DELISTED
QEP RESOURCES, INC.
QEP
| $53.2M | 0.07% |
6,829,843
-1,035,041
| -13% | -$8.26M |
|
355
Restaurant Brands International
QSR
$28.2B
| $53.1M | 0.07% |
816,097
-270,784
| -25% | -$16.6M |
|
356
Encompass Health
EHC
$11.9B
| $53M | 0.07% |
1,140,355
+489,199
| +75% | +$24.8M |
|
|
COUP
357
DELISTED
Coupa Software Incorporated
COUP
| $53M | 0.07% |
582,002
+380,244
| +188% | +$32.6M |
|
358
Tapestry
TPR
$26B
| $52.8M | 0.07% |
1,625,964
-277,019
| -15% | -$9.71M |
|
359
Toronto Dominion Bank
TD
$194B
| $52.4M | 0.07% |
964,962
+48,998
| +5% | +$2.71M |
|
360
TransUnion
TRU
$16.2B
| $52.4M | 0.07% |
783,516
+607,719
| +346% | +$37.6M |
|
|
UNIT
361
Uniti Group
UNIT
$2.42B
| $52.3M | 0.07% |
4,673,130
+4,637,815
| +13,133% | +$67.9M |
|
362
Arch Capital
ACGL
$33.9B
| $52.2M | 0.07% |
1,616,307
+84,565
| +6% | +$2.57M |
|
|
VSM
363
DELISTED
Versum Materials, Inc.
VSM
| $52.2M | 0.07% |
1,037,735
-1,035,571
| -50% | -$41.2M |
|
364
PUT
Snap
SNAP
$8.86B
| $52.1M | 0.07% |
4,727,300
+605,000
| +15% | +$5.14M |
|
365
Veeva Systems
VEEV
$40.3B
| $52M | 0.07% |
410,094
+105,070
| +34% | +$11.9M |
|
366
Tower Semiconductor
TSEM
$25.2B
| $51.9M | 0.07% |
3,134,458
+988,789
| +46% | +$15.8M |
|
367
Fidelity National Financial
FNF
$12.7B
| $51.7M | 0.07% |
1,472,274
-675,037
| -31% | -$22.6M |
|
368
Masco
MAS
$14.5B
| $51.5M | 0.07% |
1,309,440
-1,031,125
| -44% | -$36.8M |
|
369
Banco Bradesco
BBD
$33.9B
| $51M | 0.07% |
7,472,419
+6,503,090
| +671% | +$46.8M |
|
|
370
CALL
Bristol-Myers Squibb
BMY
$137B
| $50.9M | 0.07% |
1,067,100
+783,100
| +276% | +$39M |
|
371
Skyworks Solutions
SWKS
$10.1B
| $50.8M | 0.07% |
615,412
+455,988
| +286% | +$35.2M |
|
|
CMA
372
DELISTED
Comerica
CMA
| $50.5M | 0.07% |
688,434
+57,964
| +9% | +$4.65M |
|
|
AYX
373
DELISTED
Alteryx Inc
AYX
| $50.2M | 0.06% |
598,709
+478,455
| +398% | +$34.5M |
|
|
MYOK
374
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $50.1M | 0.06% |
963,453
+96,833
| +11% | +$4.46M |
|
375
Regency Centers
REG
$13.9B
| $49.9M | 0.06% |
739,638
-195,781
| -21% | -$12.5M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.